CCAUX | FTFQX | CCAUX / FTFQX | |
Total Expense Ratio | 0.51 | 0.76 | 67% |
Annual Report Gross Expense Ratio | 0.58 | 0.76 | 76% |
Fund Existence | 9 years | 7 years | - |
Gain YTD | -2.604 | -2.358 | 110% |
Front Load | N/A | 4% | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 309M | 12.5B | 2% |
Annual Yield % from dividends | 3.90 | 3.59 | 109% |
Returns for 1 year | -1.23 | -1.28 | 96% |
Returns for 3 years | 9.60 | 5.69 | 169% |
Returns for 5 years | -1.39 | -4.36 | 32% |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SHSSX | 66.51 | -0.33 | -0.49% |
BlackRock Health Sciences Opps Instl | |||
SLVYX | 25.37 | -0.23 | -0.90% |
Saratoga Large Capitalization Value A | |||
TRDFX | 11.80 | -0.20 | -1.67% |
Steward Values Enhanced SmMidCapA | |||
TEMRX | 8.58 | -0.15 | -1.72% |
Nuveen Emerging Markets Eq A | |||
GLVCX | 71.45 | -1.33 | -1.83% |
Invesco Global Focus C |